Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/S ratio is N/A as of 2026-10-06T14:26:55.612Z.
Calculation as of: 2026-10-06T14:26:55.612Z.
Quote observation: 2026-10-06T14:25:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 2eba736d2827de544c9f141b3fafa3dea8ffa5f0a614b8c2b2ac1915a5af89f6
Current P/S: FMP quote market capitalization / TTM revenue. Historical estimates use price and reported weighted-average shares; daily points use adjusted close × quarterly weighted-average shares / TTM revenue. Historical series through 2026-05-13.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PS RATIO
N/A
PS RATIO AVG TTM
0.89
PS RATIO AVG 3Y
38.57
PS RATIO AVG 5Y
N/A
PS RATIO AVG 10Y
N/A
PS RATIO AVG 15Y
N/A
PS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$259.91M
PS Ratio
93.19
TTM Avg
82.20
3Y Avg
35.74
5Y Avg
24.54
Market Cap
$250.09M
PS Ratio
N/A
TTM Avg
557.62
3Y Avg
557.62
5Y Avg
557.62
Market Cap
$261.43M
PS Ratio
N/A
TTM Avg
8336935.98
3Y Avg
3234328.97
5Y Avg
2173022.38
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Century Therapeutics, Inc. (IPSC) | $255.42M | N/A | 0.89 | 38.57 | N/A |
| Anika Therapeutics, Inc. (ANIK)vs › | $255.89M | 2.12 | 1.86 | 1.92 | 2.22 |
| AC Immune S.A. (ACIU)vs › | $256.98M | 11.84 | 46.34 | 33239.72 | 23903.84 |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $259.91M | 93.19 | 82.20 | 35.74 | 24.54 |
| Lexeo Therapeutics, Inc. Common Stock (LXEO)vs › | $250.09M | N/A | 557.62 | 557.62 | 557.62 |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $261.43M | N/A | 8336935.98 | 3234328.97 | 2173022.38 |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $264.16M | N/A | N/A | N/A | N/A |
| Invivyd, Inc. (IVVD)vs › | $246.20M | 4.22 | 5.57 | 10.86 | 10.86 |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $244.47M | N/A | N/A | N/A | N/A |
| Lifecore Biomedical, Inc. (LFCR)vs › | $243.91M | N/A | 1.88 | 1.67 | 1.36 |
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $0 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-13 |
| Q4 FY2025Period ended 2025-12-31 | $0 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-12 |
| Q1 FY2026Period ended 2026-03-31 | $0 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-13 |
| Q2 FY2026Period ended 2026-06-30 | $0 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-12 |
| TTM revenue | $0 |
The current P/S calculation cannot be reconciled from the stored quote and revenue inputs.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
P/S Ratio
N/A
Market Cap / Trailing Twelve-Month Revenue
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PS RATIO |
|---|---|
| 2026-05-13 | 1.81 |
| 2026-05-12 | 1.82 |
| 2026-05-11 | 1.82 |
| 2026-05-08 | 1.82 |
| 2026-05-07 | 1.83 |
| 2026-05-06 | 1.86 |
| 2026-05-05 | 1.82 |
| 2026-05-04 | 1.82 |
| 2026-05-01 | 1.83 |
| 2026-04-30 | 1.82 |
| 2026-04-29 | 1.74 |
| 2026-04-28 | 1.74 |
| 2026-04-27 | 1.78 |
| 2026-04-24 | 1.76 |
| 2026-04-23 | 1.79 |
| 2026-04-22 | 1.93 |
| 2026-04-21 | 1.82 |
| 2026-04-20 | 1.86 |
| 2026-04-17 | 2.06 |
| 2026-04-16 | 1.93 |
| 2026-04-15 | 2.05 |
| 2026-04-14 | 1.88 |
| 2026-04-13 | 1.80 |
| 2026-04-10 | 1.78 |
| 2026-04-09 | 1.79 |
| 2026-04-08 | 1.82 |
| 2026-04-07 | 1.79 |
| 2026-04-06 | 1.74 |
| 2026-04-02 | 1.69 |
| 2026-04-01 | 1.74 |
| 2026-03-31 | 1.79 |
| 2026-03-30 | 1.61 |
| 2026-03-27 | 1.60 |
| 2026-03-26 | 1.63 |
| 2026-03-25 | 1.64 |
| 2026-03-24 | 1.78 |
| 2026-03-23 | 1.88 |
| 2026-03-20 | 1.92 |
| 2026-03-19 | 1.97 |
| 2026-03-18 | 1.82 |
| 2026-03-17 | 1.82 |
| 2026-03-16 | 1.93 |
| 2026-03-13 | 1.86 |
| 2026-03-12 | 1.91 |
| 2026-03-11 | 2.08 |
| 2026-03-10 | 2.11 |
| 2026-03-09 | 2.24 |
| 2026-03-06 | 1.95 |
| 2026-03-05 | 1.95 |
| 2026-03-04 | 1.85 |
| 2026-03-03 | 1.74 |
| 2026-03-02 | 1.72 |
| 2026-02-27 | 1.77 |
| 2026-02-26 | 1.71 |
| 2026-02-25 | 1.66 |
| 2026-02-24 | 1.62 |
| 2026-02-23 | 1.55 |
| 2026-02-20 | 1.57 |
| 2026-02-19 | 1.63 |
| 2026-02-18 | 1.60 |
| 2026-02-17 | 1.47 |
| 2026-02-13 | 1.34 |
| 2026-02-12 | 1.34 |
| 2026-02-11 | 1.37 |
| 2026-02-10 | 1.47 |
| 2026-02-09 | 1.49 |
| 2026-02-06 | 1.30 |
| 2026-02-05 | 1.27 |
| 2026-02-04 | 1.37 |
| 2026-02-03 | 1.40 |
| 2026-02-02 | 1.40 |
| 2026-01-30 | 1.45 |
| 2026-01-29 | 1.53 |
| 2026-01-28 | 1.80 |
| 2026-01-27 | 2.02 |
| 2026-01-26 | 1.97 |
| 2026-01-23 | 1.85 |
| 2026-01-22 | 1.76 |
| 2026-01-21 | 1.56 |
| 2026-01-20 | 1.46 |
| 2026-01-16 | 1.66 |
| 2026-01-15 | 1.75 |
| 2026-01-14 | 1.54 |
| 2026-01-13 | 1.64 |
| 2026-01-12 | 1.56 |
| 2026-01-09 | 1.48 |
| 2026-01-08 | 1.35 |
| 2026-01-07 | 0.99 |
| 2026-01-06 | 0.69 |
| 2026-01-05 | 0.76 |
| 2026-01-02 | 0.76 |
| 2025-12-31 | 0.76 |
| 2025-12-30 | 0.76 |
| 2025-12-29 | 0.76 |
| 2025-12-26 | 0.83 |
| 2025-12-24 | 0.79 |
| 2025-12-23 | 0.75 |
| 2025-12-22 | 0.66 |
| 2025-12-19 | 0.69 |
| 2025-12-18 | 0.58 |
| 2025-12-17 | 0.51 |
| 2025-12-16 | 0.47 |
| 2025-12-15 | 0.44 |
| 2025-12-12 | 0.43 |
| 2025-12-11 | 0.45 |
| 2025-12-10 | 0.45 |
| 2025-12-09 | 0.45 |
| 2025-12-08 | 0.43 |
| 2025-12-05 | 0.40 |
| 2025-12-04 | 0.40 |
| 2025-12-03 | 0.39 |
| 2025-12-02 | 0.41 |
| 2025-12-01 | 0.41 |
| 2025-11-28 | 0.42 |
| 2025-11-26 | 0.41 |
| 2025-11-25 | 0.41 |
| 2025-11-24 | 0.40 |
| 2025-11-21 | 0.37 |
| 2025-11-20 | 0.37 |
| 2025-11-19 | 0.39 |
| 2025-11-18 | 0.37 |
| 2025-11-17 | 0.37 |
| 2025-11-14 | 0.36 |
| 2025-11-13 | 0.35 |
| 2025-11-12 | 0.43 |
| 2025-11-11 | 0.43 |
| 2025-11-10 | 0.41 |
| 2025-11-07 | 0.40 |
| 2025-11-06 | 0.41 |
| 2025-11-05 | 0.42 |
| 2025-11-04 | 0.43 |
| 2025-11-03 | 0.45 |
| 2025-10-31 | 0.44 |
| 2025-10-30 | 0.45 |
| 2025-10-29 | 0.44 |
| 2025-10-28 | 0.47 |
| 2025-10-27 | 0.45 |
| 2025-10-24 | 0.44 |
| 2025-10-23 | 0.45 |
| 2025-10-22 | 0.43 |
| 2025-10-21 | 0.43 |
| 2025-10-20 | 0.43 |
| 2025-10-17 | 0.41 |
| 2025-10-16 | 0.42 |
| 2025-10-15 | 0.43 |
| 2025-10-14 | 0.42 |
| 2025-10-13 | 0.42 |
| 2025-10-10 | 0.43 |
| 2025-10-09 | 0.45 |
| 2025-10-08 | 0.44 |
| 2025-10-07 | 0.42 |
| 2025-10-06 | 0.42 |
| 2025-10-03 | 0.39 |
| 2025-10-02 | 0.38 |
| 2025-10-01 | 0.38 |
| 2025-09-30 | 0.38 |
| 2025-09-29 | 0.38 |
| 2025-09-26 | 0.38 |
| 2025-09-25 | 0.37 |
| 2025-09-24 | 0.37 |
| 2025-09-23 | 0.37 |
| 2025-09-22 | 0.36 |
| 2025-09-19 | 0.36 |
| 2025-09-18 | 0.38 |
| 2025-09-17 | 0.37 |
| 2025-09-16 | 0.37 |
| 2025-09-15 | 0.38 |
| 2025-09-12 | 0.38 |
| 2025-09-11 | 0.39 |
| 2025-09-10 | 0.38 |
| 2025-09-09 | 0.38 |
| 2025-09-08 | 0.39 |
| 2025-09-05 | 0.38 |
| 2025-09-04 | 0.36 |
| 2025-09-03 | 0.35 |
| 2025-09-02 | 0.36 |
| 2025-08-29 | 0.37 |
| 2025-08-28 | 0.38 |
| 2025-08-27 | 0.39 |
| 2025-08-26 | 0.38 |
| 2025-08-25 | 0.39 |
| 2025-08-22 | 0.41 |
| 2025-08-21 | 0.41 |
| 2025-08-20 | 0.41 |
| 2025-08-19 | 0.42 |
| 2025-08-18 | 0.43 |
| 2025-08-15 | 0.42 |
| 2025-08-14 | 0.41 |
| 2025-08-13 | 0.40 |
| 2025-08-12 | 0.39 |
| 2025-08-11 | 0.37 |
| 2025-08-08 | 0.38 |
| 2025-08-07 | 0.40 |
| 2025-08-06 | 0.41 |
| 2025-08-05 | 0.42 |
| 2025-08-04 | 0.42 |
| 2025-08-01 | 0.40 |
| 2025-07-31 | 0.41 |
| 2025-07-30 | 0.43 |
| 2025-07-29 | 0.44 |
| 2025-07-28 | 0.48 |
| 2025-07-25 | 0.47 |
| 2025-07-24 | 0.49 |
| 2025-07-23 | 0.48 |
| 2025-07-22 | 0.43 |
| 2025-07-21 | 0.43 |
| 2025-07-18 | 0.44 |
| 2025-07-17 | 0.43 |
| 2025-07-16 | 0.45 |
| 2025-07-15 | 0.43 |
| 2025-07-14 | 0.45 |
| 2025-07-11 | 0.45 |
| 2025-07-10 | 0.46 |
| 2025-07-09 | 0.47 |
| 2025-07-08 | 0.42 |
| 2025-07-07 | 0.41 |
| 2025-07-03 | 0.42 |
| 2025-07-02 | 0.42 |
| 2025-07-01 | 0.41 |
| 2025-06-30 | 0.42 |
| 2025-06-27 | 0.39 |
| 2025-06-26 | 0.43 |
| 2025-06-25 | 0.42 |
| 2025-06-24 | 0.45 |
| 2025-06-23 | 0.43 |
| 2025-06-20 | 0.44 |
| 2025-06-18 | 0.44 |
| 2025-06-17 | 0.44 |
| 2025-06-16 | 0.44 |
| 2025-06-13 | 0.43 |
| 2025-06-12 | 0.45 |
| 2025-06-11 | 0.45 |
| 2025-06-10 | 0.48 |
| 2025-06-09 | 0.47 |
| 2025-06-06 | 0.46 |
| 2025-06-05 | 0.42 |
| 2025-06-04 | 0.42 |
| 2025-06-03 | 0.43 |
| 2025-06-02 | 0.41 |
| 2025-05-30 | 0.40 |
| 2025-05-29 | 0.42 |
| 2025-05-28 | 0.42 |
| 2025-05-27 | 0.42 |
| 2025-05-23 | 0.42 |
| 2025-05-22 | 0.43 |
| 2025-05-21 | 0.43 |
| 2025-05-20 | 0.45 |
| 2025-05-19 | 0.42 |
| 2025-05-16 | 0.42 |
| 2025-05-15 | 6.17 |
| 2025-05-14 | 5.84 |
| 2025-05-13 | 6.28 |
| 2025-05-12 | 6.26 |
| 2025-05-09 | 6.41 |
| 2025-05-08 | 6.21 |
| 2025-05-07 | 6.23 |
| 2025-05-06 | 6.33 |
| 2025-05-05 | 6.70 |
| 2025-05-02 | 6.56 |
| 2025-05-01 | 6.63 |
Showing the most recent 260 of 1,001 data points. The chart above shows the full history.